SB247
Interim Study (House)prohibiting network exclusion for pharmacies that refuse to dispense a prescription of the PBM reimbursement that is below the pharmacy's acquisition cost.
Status
Hearing
No upcoming hearing scheduled.
Testimony
3 total submissions
Bill Docket
Refer for Interim Study: MA VV 01/07/2026 HJ 1
HouseJanuary 07, 2026
Committee Report: Refer for Interim Study 10/28/2025 (Vote 17-0; CC) HC 51 P. 5
HouseNovember 13, 2025
Executive Session: 10/28/2025 11:00 am GP 229
HouseOctober 08, 2025
Full Committee Work Session: 09/10/2025 10:00 am GP 229
HouseAugust 27, 2025
Retained in Committee
HouseMay 28, 2025
Executive Session: 05/27/2025 01:15 pm LOB 302-304
HouseMay 21, 2025
Subcommittee Work Session: 05/07/2025 10:00 am LOB 302-304
HouseApril 30, 2025
Public Hearing: 04/23/2025 11:00 am LOB 302-304
HouseApril 16, 2025
Introduced (in recess of) 03/27/2025 and referred to Commerce and Consumer Affairs HJ 11 P. 113
HouseMarch 28, 2025
Ought to Pass with Amendment #2025-1401s, MA, VV; OT3rdg; 03/27/2025; SJ 9
SenateMarch 27, 2025
Sen. Birdsell Floor Amendment # 2025-1401s, AA, VV; 03/27/2025; SJ 9
SenateMarch 27, 2025
Committee Amendment # 2025-1173s, AF, VV; 03/27/2025; SJ 9
SenateMarch 27, 2025
SB 247 was Removed from the Consent Calendar; 03/27/2025; SJ 9
SenateMarch 27, 2025
Committee Report: Ought to Pass with Amendment # 2025-1173s, 03/27/2025; Vote 5-0; CC; SC 14
SenateMarch 20, 2025
Hearing: 03/12/2025, Room 101, LOB, 10:30 am; SC 12
SenateMarch 05, 2025
Introduced 01/09/2025 and Referred to Health and Human Services; SJ 3
SenateJanuary 23, 2025